BLOG

What Happens on Infusion Day in Adipose Stem Cell Therapy in Osaka?

Published 2026.10.04 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you are considering adipose-derived stem cell therapy in Japan, the infusion day is often the part that raises the most practical questions. How long does it take? Is hospital admission needed? What happens before and after the drip? This article walks through what international patients can generally expect, and which points are worth confirming with a doctor in advance.

In short, treatment at Grand Green Osaka Umekita Clinic is provided on an outpatient basis. Cells from your own fat tissue are cultured and then returned to your body by intravenous (IV) infusion. Exact timing, dosage, and suitability are decided by the doctor after a consultation, so the points below are a general orientation rather than a personal plan.

What Is Being Infused, and Why Does It Come Months After Fat Collection?

The infusion uses mesenchymal stem cells that were obtained from a very small amount of your own fat tissue. After collection, the cells are sent to a specialized facility where they are cultured and expanded. Because culturing takes time, the infusion does not happen on the same day as fat collection. It is a separate visit scheduled once the cells are ready.

Using your own (autologous) cells is generally associated with a lower risk of rejection or allergic reaction than donor cells or artificial materials. However, a lower risk is not the same as no risk, and individual responses can differ. Your doctor can explain the possible adverse events in your situation.

How Does an Outpatient IV Infusion Work?

The cultured cells are administered through an IV drip, much like other intravenous treatments. Because the cells are given through the bloodstream, the approach is sometimes described as whole-body rather than targeted at a single site. Some studies have reported that infused mesenchymal stem cells can accumulate at sites of inflammation or damage, a phenomenon often called homing, although how much this contributes to any clinical result in a given person remains under investigation.

Since this is an outpatient treatment, hospitalization is not required. This can make it easier to fit a visit around travel or work, but you should still ask the clinic how much time to set aside for check-in, preparation, the infusion itself, and any observation afterward.

What Might Happen Before and After Your Infusion Visit?

Before the infusion, a doctor will typically confirm your current health status and ask about medications, allergies, and recent illnesses. If you have changes in your health between the fat collection and the infusion, it is important to tell the medical team, because they may need to reassess the plan.

After the infusion, staff may observe you for a period and explain what to watch for at home. Mild reactions such as temporary discomfort at the injection site or a feeling of tiredness have been described with intravenous treatments in general, but the possible effects of this specific therapy should be reviewed with your doctor, along with who to contact if something feels unusual after you return home.

What Should International Patients Prepare Before Infusion Day?

Travel adds another layer of planning. Consider the following questions before you book flights or accommodation:

How many visits are expected in total, and how far apart are they?
Is the infusion date fixed, or can it shift if the culturing period changes?
How should I share my medical records and medication list, and in what language?
Whom can I contact for follow-up questions after I leave Osaka?
Which parts of the process are explained in my language?

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, and the clinic offers an information page for international patients in multiple languages. Using it before your first contact can help you prepare questions in advance.

Understanding the Legal Framework, Costs, and Limits of the Treatment

In Japan, this therapy is offered as a self-pay (non-insured) treatment, and it is provided under a regenerative medicine provision plan in line with the Act on the Safety of Regenerative Medicine. This framework is intended to support safety management, but it does not guarantee any particular result. Adipose-derived stem cell therapy is not a replacement for standard medical care, and it should not be used as a reason to stop treatment you are already receiving.

Costs, the number of treatments, possible risks and side effects, and whether the therapy is appropriate for you must all be confirmed by a doctor at a consultation. Please be cautious about any information that promises specific outcomes, and ask the clinic to explain both the potential benefits and the uncertainties in plain terms.

Key Takeaways Before You Plan Your Visit

The infusion day is a straightforward outpatient step, but it depends on earlier stages: fat collection, culturing, and a doctor’s assessment. Understanding the sequence helps you plan travel and ask better questions. A consultation with a doctor is the right place to confirm whether this therapy is suitable, what it involves for you, and what it costs.

If you are in Osaka or planning a trip to Japan, consider booking a consultation at Grand Green Osaka Umekita Clinic so that your questions about schedule, safety, and follow-up can be answered individually.

Infusion Day Overview

1Fat collectionSmall amount, local anesthesia
2Cell culturingAt a specialized facility
3Doctor checkHealth review before infusion
4IV infusionOutpatient, no admission
5Follow-upAsk who to contact

This figure is a conceptual summary of the article content

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›